| CAS: | 74430-89-0 | |
| 分子式: | C26H56NO6P | |
| 分子量: | 509.70 | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||
| O863882 | MACKLIN | 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine | >99% | 2323元/5mg; | 咨询 | ||||||||||||||||||||||||||||
储存：-20°C | |||||||||||||||||||||||||||||||||
| 878120P | Avanti | C18 Lyso PAF | Avanti Polar Lipids 878120P, powder | 1522.2元/5 MG; | 咨询 | ||||||||||||||||||||||||||||
产品说明 一般描述 C18-lysoPAF, also known as 1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine, is a synthetic lyso-platelet activating factor (PAF). It is a precursor and metabolite of 1-O-octadecyl-2-acetyl-sn-glycero-3-phosphocholine (C18:0 PAF). Lyso-platelet activating factor (PAF) is synthesized from PAF acetylhydrolases by the degradation of PAF. Additionally, it is also synthesized in the remodeling pathway from 1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine (1-alkyl-phosphatidylcholine) by the enzyme phospholipase. 应用 C18-lysoPAF (1-O-octadecyl-2-hydroxy-sn-glycero-3-phosphocholine) has been used to study its effect on human eosinophil degranulation. 包装 5 mL Amber Glass Screw Cap Vial (878120P-5mg) 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||
m.cnreagent.com